Skip to main content
close menu
close menu

Search UK HealthCare

Menu
Open search dialog Magnifying Glass My UK HealthCare

Lowell B. Anthony, MD, FACP

Chief, Division of Medical Oncology
Lowell B. Anthony, MD, FACP
Request an Appointment Physician Referral

  • About

    Lowell Anthony joined the UK Markey Cancer Center with more than two decades of experience in oncology and a special focus in gastrointestinal and neuroendocrine oncology. His clinical interests include drug development ranging from Phase I to III clinical trials. Agents targeting specific cellular signaling pathways and injectable radiolabeled compounds make up his past and current clinical investigative interests. He brings a clinical correlative component to complement the ongoing translational activities at Markey Cancer Center.

    Dr. Anthony attended Vanderbilt University Medical School, where he also completed a medical residency and fellowship training in medical oncology and clinical pharmacology. He has previously been on the medical faculties at Vanderbilt University and the Louisiana State University Health Sciences Center in New Orleans.

    Personal Statement

     

    Lowell Anthony listens to Geri's heart during a followup visit. Read her story »
    Lowell Anthony listens to Geri's heart during a followup visit.

    It takes a village to treat cancer, so when the patient is initially evaluated at Markey Cancer Center, a care plan is developed across specialties. So it's more encompassing than just a single visit to one specialist who treats cancer. Right now in oncology, the most exciting development is immunotherapy. Our challenge is to find out how we integrate this into other forms of how we treat cancer; both from other medicine, other drugs and potentially other modalities such as radiation.

    Faculty Rank

    Professor of Medicine

    Degree

    Vanderbilt University, School of Medicine, Nashville, Tenn.

    Residency

    Vanderbilt University, School of Medicine, Nashville, Tenn.

    Fellowship

    Medical Oncology and Clinical Pharmacology, Vanderbilt University, School of Medicine, Nashville, Tenn.

    Certifications and Special Training

    American Board of Internal Medicine

    American Board of Internal Medicine, Medical Oncology

    Fellow of the American College of Physicians

  • Publications

    Publications

    1. Defining the optimal timing of adjuvant therapy for resected pancreatic adenocarcinoma: A statewide cancer registry analysis. J Surg Oncol. 2016 May 30. Saeed H, Hnoosh D, Huang B, Durbin EB, McGrath PC, Desimone P, Maynard E, Anthony LB, Dineen SP, Hosein PJ, Tzeng CD.
      View Publication
    2. Unexpected Cardiac Masses. JAMA Oncol. 2015 Dec;1(9):1343-4. Hilal T, Anthony LB, Sorrell VL.
      View Publication
    3. Impact of Previous Somatostatin Analogue Use on the Activity of Everolimus in Patients with Advanced Neuroendocrine Tumors: Analysis from the Phase III RADIANT-2 Trial. Neuroendocrinology. 2015;102(1-2):18-25.Anthony LB, Pavel ME, Hainsworth JD, Kvols LK, Segal S, Hörsch D, Van Cutsem E, Öberg K, Yao JC.
      View Publication
    4. Practical guide to supportive care of patients with functional neuroendocrine tumors. Semin Oncol. 2013 Feb; 40(1):45-55. PMID: 23391112. Anthony LB.
      View Publication
    5. Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study. Oncologist. 2013; 18(1):46-53. PMID: 23263288. Castellano D, Bajetta E, Panneerselvam A, Saletan S, Kocha W, O'Dorisio T, Anthony LB, Hobday T.
      View Publication